Applications for both streams are due February 25
Vaccine delivery system and antibody discovery platform have roots in UBC research.
U.S. FDA Emergency Use Authorization received as a Monotherapy for the Treatment of COVID-19
UBC companies AbCellera, NZ Technologies and Terramera among awardees